Trademarkia Logo

Australia

AU$
BUPLANT
Cancelled: Cancelled at the request of IB

Last updated on 29 Sept 2020

Owner Info

Titan Pharmaceuticals, Inc.

400 Oyster Point Boulevard, Suite 505

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

1811348 filed on 26 Aug 2016

Correspondent

Jennifer Lee Taylor Morrison & Foerster LLP

425 Market Street,

San Francisco CA 94105,

UNITED STATES OF AMERICA

BUPLANT

Classification Information


Class [005]
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained releas Read More

Mark Details


Serial Number

1811348

Registered On

26 Aug 2016

Renewal On

NA

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
29th Sept 2020Status change to Voided
23rd Mar 2017IP Right Registration Published
20th Mar 2017Register Trade Mark
20th Mar 2017Application Status
12th Jan 2017IP Right Acceptance Published
9th Jan 2017Amend Status from Awaiting Advertisement
12th Dec 2016Clear Examination report approved
12th Dec 2016User Created Notice correspondence sent
12th Dec 2016Application Accepted correspondence sent
1st Dec 2016IP Right Filed Published